0001144204-19-004172.txt : 20190131
0001144204-19-004172.hdr.sgml : 20190131
20190131192153
ACCESSION NUMBER: 0001144204-19-004172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190129
FILED AS OF DATE: 20190131
DATE AS OF CHANGE: 20190131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ren Ken Keyong
CENTRAL INDEX KEY: 0001545181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 19557322
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
4
1
tv512146_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-01-29
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001545181
Ren Ken Keyong
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DRIVE, SUITE 300
ROCKVILLE
MD
20850
1
1
0
0
Chief Executive Officer
Stock Options (Right to Buy)
0.88
2019-01-29
4
A
0
75000
0
A
2019-01-29
2026-03-02
Common Stock
75000
75000
D
On March 2, 2016, the reporting person was granted an option to purchase shares of common stock that would vest upon achievement of certain performance based conditions. On January 29, 2019, the Compensation Committee certified that the performance based condition relating to the vesting of 75,000 options had been satisfied on October 18, 2018, resulting in vesting of the options.
/s/ Cynthia W. Hu, attorney-in-fact for Ken K. Ren
2019-01-31